Johnson & Johnson's COVID-19 Vaccine

Learn More

CDC Advisory Committee Recommends Johnson & Johnson COVID-19 Vaccine as a Booster

Learn More

Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review

Learn More

Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response

Learn More

Johnson & Johnson Statement on COVID-19 Vaccine

A photo of a person typing on a computer keyboard

Fraudulent Advertising for COVID-19 Vaccines: How to Identify Common Scams

Learn More

accines are critical to tackling the COVID-19 pandemic. We are bringing a vaccine to the public on a not-for-profit basis for emergency pandemic use.

Our vaccine development technology, scientific expertise and global manufacturing capabilities provide a foundation to develop a vaccine candidate and upscale production so that we can get it in the hands of those who need it most, as quickly and as safely as possible.

The availability of an Emergency Use Authorized single-dose COVID-19 vaccine could potentially protect hundreds of millions of people from serious and fatal outcomes of the disease. It also offers the hope of helping ease the burden placed on healthcare systems and communities.

Learn More About Our COVID-19 Vaccine Clinical Trials and Our Commitment to Safety Transparency

At Johnson & Johnson, there is no greater priority than the safety and wellbeing of the patients, customers and people we serve every day, around the world.

Learn More